Servier Canada Release: Once-Daily Anticoagulant LIXIANA (Edoxaban) Approved In Canada For Stroke Prevention In Atrial Fibrillation And For The Treatment And Prevention Of Recurrent Deep-Vein Thrombosis And Pulmonary Embolism Published: Nov 10, 2016 Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news